Mobile

A randomised, double-blind, parallel group trial to assess the variability and treatment effect size for a Neuropathic Pain offset design

Mise à jour : Il y a 5 ans
Référence : EUCTR2004-004837-33

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To estimate the difference in average daily pain score (ADPS) after 4 weeks in patients maintained on the ‘standard’ dose of gabapentin compared to those on a reduced dose of gabapentin. To estimate the variability of ADPS at 4 weeks for both groups. To investigate the time to onset of maximum pain following gabapentin dose-reduction.

Liens